Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocarditis | 23 | 2024 | 802 | 6.940 |
Why?
|
Anthracyclines | 12 | 2023 | 286 | 2.720 |
Why?
|
Magnetic Resonance Imaging, Cine | 22 | 2021 | 1091 | 2.480 |
Why?
|
Neoplasms | 44 | 2024 | 22371 | 2.010 |
Why?
|
Myocardium | 21 | 2024 | 4788 | 1.960 |
Why?
|
Ventricular Remodeling | 15 | 2024 | 1281 | 1.850 |
Why?
|
Cardiovascular Diseases | 27 | 2024 | 15662 | 1.790 |
Why?
|
Heart Failure | 25 | 2024 | 11879 | 1.670 |
Why?
|
Ventricular Function, Left | 26 | 2024 | 3941 | 1.650 |
Why?
|
Cardiomyopathies | 11 | 2023 | 2056 | 1.630 |
Why?
|
Heart Diseases | 10 | 2023 | 2819 | 1.570 |
Why?
|
Death, Sudden, Cardiac | 8 | 2020 | 1567 | 1.530 |
Why?
|
HIV | 7 | 2020 | 1597 | 1.500 |
Why?
|
HIV Infections | 22 | 2023 | 17569 | 1.420 |
Why?
|
Heart Atria | 10 | 2017 | 1361 | 1.370 |
Why?
|
Stroke Volume | 29 | 2024 | 5622 | 1.330 |
Why?
|
Ventricular Dysfunction, Left | 15 | 2022 | 2145 | 1.280 |
Why?
|
Antibiotics, Antineoplastic | 6 | 2023 | 681 | 1.170 |
Why?
|
Immunotherapy | 14 | 2024 | 4755 | 1.140 |
Why?
|
Doxorubicin | 7 | 2024 | 2234 | 1.110 |
Why?
|
Heart Ventricles | 10 | 2021 | 3841 | 1.050 |
Why?
|
Antineoplastic Agents | 18 | 2023 | 13676 | 0.990 |
Why?
|
Hypertrophy, Left Ventricular | 7 | 2021 | 856 | 0.950 |
Why?
|
Fibrosis | 13 | 2024 | 2080 | 0.930 |
Why?
|
Gadolinium | 5 | 2020 | 964 | 0.920 |
Why?
|
Plaque, Atherosclerotic | 3 | 2021 | 1551 | 0.900 |
Why?
|
Atherosclerosis | 5 | 2023 | 3433 | 0.900 |
Why?
|
Registries | 11 | 2023 | 8375 | 0.870 |
Why?
|
Cicatrix | 3 | 2014 | 798 | 0.860 |
Why?
|
Cardiovascular Agents | 4 | 2023 | 849 | 0.850 |
Why?
|
Echocardiography | 20 | 2024 | 5047 | 0.790 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2024 | 374 | 0.780 |
Why?
|
Cardiac Imaging Techniques | 4 | 2021 | 280 | 0.770 |
Why?
|
Coronary Vasospasm | 1 | 2022 | 81 | 0.770 |
Why?
|
Atrial Fibrillation | 9 | 2023 | 5176 | 0.760 |
Why?
|
Contrast Media | 16 | 2020 | 5330 | 0.730 |
Why?
|
Humans | 187 | 2024 | 768166 | 0.720 |
Why?
|
Middle Aged | 92 | 2024 | 223492 | 0.700 |
Why?
|
Pulmonary Veins | 4 | 2014 | 758 | 0.700 |
Why?
|
Echocardiography, Doppler | 7 | 2013 | 898 | 0.700 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2024 | 12252 | 0.700 |
Why?
|
Retrospective Studies | 43 | 2024 | 81762 | 0.670 |
Why?
|
Heart | 12 | 2024 | 4446 | 0.670 |
Why?
|
Magnetic Resonance Imaging | 26 | 2021 | 36743 | 0.660 |
Why?
|
Symporters | 1 | 2022 | 363 | 0.650 |
Why?
|
Head and Neck Neoplasms | 5 | 2023 | 2931 | 0.650 |
Why?
|
Cocaine-Related Disorders | 2 | 2019 | 458 | 0.650 |
Why?
|
Myocardial Infarction | 11 | 2022 | 11519 | 0.640 |
Why?
|
Electrocardiography | 10 | 2021 | 6412 | 0.640 |
Why?
|
Pericardial Effusion | 1 | 2021 | 246 | 0.640 |
Why?
|
Atrial Function, Left | 2 | 2017 | 188 | 0.640 |
Why?
|
Male | 111 | 2024 | 364719 | 0.620 |
Why?
|
Lymphocyte Count | 1 | 2020 | 794 | 0.610 |
Why?
|
Aged | 69 | 2024 | 171504 | 0.610 |
Why?
|
HIV Long-Term Survivors | 1 | 2019 | 140 | 0.600 |
Why?
|
Female | 112 | 2024 | 397192 | 0.600 |
Why?
|
Patient Readmission | 5 | 2023 | 3288 | 0.590 |
Why?
|
Sleep Apnea Syndromes | 2 | 2018 | 984 | 0.590 |
Why?
|
Adrenal Cortex Hormones | 3 | 2024 | 1886 | 0.580 |
Why?
|
Sarcomeres | 2 | 2017 | 380 | 0.570 |
Why?
|
Renin-Angiotensin System | 1 | 2022 | 737 | 0.560 |
Why?
|
Predictive Value of Tests | 20 | 2022 | 15454 | 0.550 |
Why?
|
Mitral Valve | 3 | 2018 | 1475 | 0.540 |
Why?
|
Running | 5 | 2009 | 490 | 0.530 |
Why?
|
Heart Conduction System | 1 | 2021 | 1009 | 0.500 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2023 | 2055 | 0.490 |
Why?
|
Catheter Ablation | 5 | 2023 | 2780 | 0.480 |
Why?
|
Heart Rate | 7 | 2023 | 4214 | 0.470 |
Why?
|
Protease Inhibitors | 1 | 2018 | 751 | 0.470 |
Why?
|
Cranial Irradiation | 1 | 2017 | 393 | 0.470 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2018 | 843 | 0.470 |
Why?
|
Troponin T | 7 | 2024 | 787 | 0.460 |
Why?
|
Lymphoma | 1 | 2023 | 1898 | 0.450 |
Why?
|
Risk Factors | 34 | 2024 | 74944 | 0.440 |
Why?
|
Cardiomyopathy, Hypertrophic | 5 | 2017 | 1334 | 0.440 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2019 | 1243 | 0.440 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1512 | 0.440 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1561 | 0.430 |
Why?
|
Action Potentials | 1 | 2021 | 1838 | 0.430 |
Why?
|
Continuous Positive Airway Pressure | 2 | 2020 | 580 | 0.430 |
Why?
|
Carotid Arteries | 1 | 2017 | 942 | 0.420 |
Why?
|
Cardiac Volume | 1 | 2013 | 197 | 0.420 |
Why?
|
Ischemic Attack, Transient | 2 | 2019 | 877 | 0.420 |
Why?
|
Troponin | 6 | 2023 | 535 | 0.420 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2018 | 3252 | 0.420 |
Why?
|
Myocytes, Cardiac | 8 | 2018 | 1681 | 0.380 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13586 | 0.380 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2016 | 1245 | 0.380 |
Why?
|
Influenza Vaccines | 1 | 2019 | 781 | 0.380 |
Why?
|
Influenza, Human | 2 | 2021 | 1541 | 0.370 |
Why?
|
Papillomaviridae | 1 | 2017 | 1140 | 0.370 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 879 | 0.370 |
Why?
|
Incidence | 11 | 2022 | 21538 | 0.360 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2019 | 1903 | 0.360 |
Why?
|
Pneumonia, Viral | 4 | 2021 | 3238 | 0.350 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2006 | 646 | 0.350 |
Why?
|
Physical Endurance | 3 | 2009 | 369 | 0.350 |
Why?
|
Cyclooxygenase 2 | 3 | 2008 | 598 | 0.340 |
Why?
|
Prognosis | 16 | 2023 | 30010 | 0.340 |
Why?
|
Gadolinium DTPA | 7 | 2018 | 823 | 0.340 |
Why?
|
Iloprost | 2 | 2006 | 25 | 0.340 |
Why?
|
Nitric Oxide Synthase Type II | 3 | 2007 | 514 | 0.330 |
Why?
|
Sleep Apnea, Obstructive | 4 | 2020 | 1899 | 0.330 |
Why?
|
Hematology | 1 | 2022 | 243 | 0.320 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2599 | 0.320 |
Why?
|
Disease Progression | 11 | 2021 | 13671 | 0.320 |
Why?
|
Disease-Free Survival | 5 | 2020 | 6847 | 0.310 |
Why?
|
Mitral Valve Insufficiency | 5 | 2023 | 1415 | 0.310 |
Why?
|
Hypertension | 6 | 2022 | 8616 | 0.300 |
Why?
|
Breast Neoplasms | 8 | 2024 | 21206 | 0.300 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3115 | 0.300 |
Why?
|
Aging | 2 | 2020 | 8744 | 0.290 |
Why?
|
Neutrophils | 1 | 2020 | 3786 | 0.290 |
Why?
|
Physical Fitness | 2 | 2016 | 744 | 0.290 |
Why?
|
Case-Control Studies | 13 | 2024 | 22291 | 0.290 |
Why?
|
Risk Assessment | 14 | 2024 | 24315 | 0.290 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2062 | 0.280 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 2433 | 0.280 |
Why?
|
Adult | 48 | 2024 | 223646 | 0.280 |
Why?
|
Exercise Test | 8 | 2024 | 2186 | 0.280 |
Why?
|
Anti-Retroviral Agents | 4 | 2020 | 1789 | 0.270 |
Why?
|
Time Factors | 13 | 2021 | 40218 | 0.270 |
Why?
|
Aged, 80 and over | 18 | 2022 | 59629 | 0.270 |
Why?
|
Radiation Oncology | 1 | 2022 | 572 | 0.260 |
Why?
|
Coronary Artery Disease | 8 | 2019 | 6568 | 0.260 |
Why?
|
Follow-Up Studies | 14 | 2023 | 39348 | 0.260 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2006 | 107 | 0.260 |
Why?
|
Microcirculation | 1 | 2010 | 1281 | 0.250 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3514 | 0.250 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1640 | 0.250 |
Why?
|
Adenocarcinoma | 3 | 2024 | 6395 | 0.250 |
Why?
|
Body Size | 1 | 2008 | 463 | 0.240 |
Why?
|
Coronary Angiography | 7 | 2018 | 4541 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4058 | 0.240 |
Why?
|
Ventricular Function, Right | 3 | 2020 | 629 | 0.240 |
Why?
|
Ventricular Function | 1 | 2006 | 405 | 0.240 |
Why?
|
Physical Exertion | 2 | 2006 | 668 | 0.230 |
Why?
|
Heart Neoplasms | 3 | 2016 | 374 | 0.210 |
Why?
|
CD4 Lymphocyte Count | 2 | 2020 | 2596 | 0.210 |
Why?
|
Medical Oncology | 7 | 2024 | 2346 | 0.210 |
Why?
|
Triglycerides | 3 | 2020 | 2464 | 0.210 |
Why?
|
Anthropometry | 1 | 2008 | 1346 | 0.210 |
Why?
|
Cardiomegaly | 2 | 2016 | 591 | 0.200 |
Why?
|
Stroke | 4 | 2019 | 9755 | 0.200 |
Why?
|
Triage | 2 | 2021 | 997 | 0.200 |
Why?
|
Prospective Studies | 14 | 2024 | 54926 | 0.200 |
Why?
|
Blood | 1 | 2024 | 599 | 0.200 |
Why?
|
Nitrates | 2 | 2022 | 260 | 0.200 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3251 | 0.200 |
Why?
|
Carbolines | 1 | 2024 | 295 | 0.190 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2020 | 3780 | 0.190 |
Why?
|
Echocardiography, Transesophageal | 8 | 2007 | 1096 | 0.190 |
Why?
|
Thyroiditis | 1 | 2021 | 86 | 0.190 |
Why?
|
Smoking | 1 | 2018 | 9092 | 0.190 |
Why?
|
Natriuretic Peptide, Brain | 4 | 2024 | 1751 | 0.190 |
Why?
|
Vincristine | 1 | 2024 | 1040 | 0.190 |
Why?
|
Sympathetic Nervous System | 1 | 2024 | 521 | 0.190 |
Why?
|
Extracellular Space | 2 | 2013 | 563 | 0.190 |
Why?
|
Mitral Valve Prolapse | 1 | 2023 | 213 | 0.190 |
Why?
|
Mediastinal Neoplasms | 2 | 2019 | 403 | 0.190 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3436 | 0.190 |
Why?
|
Lung | 3 | 2019 | 10099 | 0.180 |
Why?
|
Cardiology | 3 | 2024 | 1702 | 0.180 |
Why?
|
Myocardial Reperfusion Injury | 3 | 2010 | 483 | 0.180 |
Why?
|
Fatal Outcome | 4 | 2019 | 1836 | 0.180 |
Why?
|
Ventricular Dysfunction | 1 | 2021 | 144 | 0.180 |
Why?
|
Giant Cells | 1 | 2021 | 187 | 0.180 |
Why?
|
Asymptomatic Diseases | 3 | 2018 | 590 | 0.180 |
Why?
|
Friedreich Ataxia | 1 | 2021 | 82 | 0.170 |
Why?
|
Sports | 1 | 2006 | 703 | 0.170 |
Why?
|
Immunologic Factors | 2 | 2020 | 1596 | 0.170 |
Why?
|
Thorax | 1 | 2023 | 557 | 0.170 |
Why?
|
Observer Variation | 4 | 2013 | 2622 | 0.170 |
Why?
|
Cause of Death | 3 | 2020 | 3721 | 0.170 |
Why?
|
Diagnosis, Differential | 11 | 2021 | 13014 | 0.170 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2023 | 2298 | 0.170 |
Why?
|
Biology | 1 | 2021 | 292 | 0.160 |
Why?
|
Reference Values | 4 | 2013 | 4938 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6526 | 0.160 |
Why?
|
Myasthenia Gravis | 1 | 2022 | 215 | 0.160 |
Why?
|
Arrhythmias, Cardiac | 3 | 2023 | 2258 | 0.160 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7454 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 11 | 2019 | 20760 | 0.160 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2021 | 125 | 0.160 |
Why?
|
Treatment Outcome | 15 | 2024 | 65371 | 0.160 |
Why?
|
Viral Load | 2 | 2019 | 3396 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.160 |
Why?
|
Prednisone | 1 | 2024 | 1567 | 0.160 |
Why?
|
Heart Failure, Diastolic | 1 | 2019 | 77 | 0.160 |
Why?
|
Calcium Channel Blockers | 1 | 2022 | 687 | 0.160 |
Why?
|
Ischemic Preconditioning, Myocardial | 2 | 2009 | 69 | 0.160 |
Why?
|
Denmark | 1 | 2021 | 776 | 0.160 |
Why?
|
Survival Rate | 4 | 2024 | 12840 | 0.150 |
Why?
|
International Classification of Diseases | 1 | 2024 | 937 | 0.150 |
Why?
|
Multivariate Analysis | 5 | 2021 | 12077 | 0.150 |
Why?
|
Amygdala | 2 | 2023 | 1380 | 0.150 |
Why?
|
Proportional Hazards Models | 6 | 2019 | 12543 | 0.150 |
Why?
|
Cyclophosphamide | 1 | 2024 | 2227 | 0.150 |
Why?
|
Coronary Vessels | 2 | 2021 | 3124 | 0.150 |
Why?
|
Peptide Fragments | 4 | 2024 | 5151 | 0.150 |
Why?
|
Sex Factors | 5 | 2021 | 10632 | 0.140 |
Why?
|
Obesity | 3 | 2016 | 13090 | 0.140 |
Why?
|
Monocytes | 3 | 2022 | 2605 | 0.140 |
Why?
|
Hospitalization | 5 | 2021 | 10840 | 0.140 |
Why?
|
Mice, Inbred C57BL | 9 | 2016 | 22379 | 0.140 |
Why?
|
Body Mass Index | 6 | 2020 | 13053 | 0.140 |
Why?
|
Edema | 1 | 2021 | 765 | 0.140 |
Why?
|
Edema, Cardiac | 1 | 2016 | 19 | 0.140 |
Why?
|
Adipose Tissue | 2 | 2020 | 3329 | 0.140 |
Why?
|
Melanoma | 4 | 2020 | 5706 | 0.140 |
Why?
|
Fluorouracil | 1 | 2022 | 1652 | 0.140 |
Why?
|
Adaptive Immunity | 1 | 2022 | 733 | 0.140 |
Why?
|
Sodium | 1 | 2022 | 1597 | 0.140 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 365 | 0.140 |
Why?
|
Young Adult | 14 | 2021 | 60066 | 0.140 |
Why?
|
Radiopharmaceuticals | 2 | 2024 | 2735 | 0.140 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 795 | 0.130 |
Why?
|
Methylprednisolone | 1 | 2018 | 386 | 0.130 |
Why?
|
Confusion | 1 | 2018 | 278 | 0.130 |
Why?
|
Immune System | 1 | 2021 | 799 | 0.130 |
Why?
|
Anticholesteremic Agents | 1 | 2023 | 972 | 0.130 |
Why?
|
Athletic Injuries | 1 | 2006 | 1245 | 0.130 |
Why?
|
Vasodilator Agents | 2 | 2014 | 990 | 0.130 |
Why?
|
Combined Modality Therapy | 3 | 2023 | 8542 | 0.130 |
Why?
|
Radiotherapy | 2 | 2020 | 1502 | 0.130 |
Why?
|
Thrombophilia | 1 | 2018 | 308 | 0.130 |
Why?
|
Hormones | 1 | 2019 | 866 | 0.130 |
Why?
|
Mortality | 2 | 2018 | 2911 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 3 | 2007 | 706 | 0.130 |
Why?
|
Glutamine | 2 | 2009 | 577 | 0.130 |
Why?
|
Coronary Circulation | 1 | 2021 | 1617 | 0.120 |
Why?
|
Mutation | 2 | 2017 | 30238 | 0.120 |
Why?
|
NG-Nitroarginine Methyl Ester | 3 | 2014 | 262 | 0.120 |
Why?
|
Radiography, Thoracic | 2 | 2019 | 1321 | 0.120 |
Why?
|
Extracellular Matrix | 2 | 2013 | 1738 | 0.120 |
Why?
|
Coronary Care Units | 1 | 2016 | 235 | 0.120 |
Why?
|
Aorta | 5 | 2020 | 2045 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1515 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2022 | 1065 | 0.120 |
Why?
|
Double-Blind Method | 3 | 2024 | 12465 | 0.120 |
Why?
|
Boston | 3 | 2020 | 9374 | 0.120 |
Why?
|
Animals | 19 | 2024 | 169246 | 0.120 |
Why?
|
Acute Coronary Syndrome | 2 | 2018 | 2194 | 0.120 |
Why?
|
Cohort Studies | 10 | 2024 | 41754 | 0.120 |
Why?
|
Papillary Muscles | 2 | 2023 | 192 | 0.120 |
Why?
|
Fistula | 2 | 2006 | 213 | 0.110 |
Why?
|
Chest Pain | 2 | 2019 | 1101 | 0.110 |
Why?
|
United States | 9 | 2023 | 73039 | 0.110 |
Why?
|
Immunosuppressive Agents | 2 | 2024 | 4206 | 0.110 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 1437 | 0.110 |
Why?
|
Pyrimidinones | 1 | 2016 | 386 | 0.110 |
Why?
|
Aneurysm, False | 2 | 2007 | 263 | 0.110 |
Why?
|
Endocarditis, Bacterial | 3 | 2006 | 436 | 0.110 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10266 | 0.110 |
Why?
|
Pericardium | 1 | 2018 | 679 | 0.110 |
Why?
|
Piperazines | 1 | 2024 | 2554 | 0.110 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2014 | 167 | 0.110 |
Why?
|
Respiratory Insufficiency | 3 | 2021 | 1240 | 0.110 |
Why?
|
Laryngeal Neoplasms | 1 | 2016 | 514 | 0.100 |
Why?
|
Recurrence | 3 | 2014 | 8509 | 0.100 |
Why?
|
ROC Curve | 1 | 2020 | 3628 | 0.100 |
Why?
|
Defibrillators, Implantable | 2 | 2021 | 1498 | 0.100 |
Why?
|
Kidney Failure, Chronic | 2 | 2020 | 2496 | 0.100 |
Why?
|
Age Factors | 5 | 2021 | 18412 | 0.100 |
Why?
|
Shock, Cardiogenic | 2 | 2016 | 711 | 0.100 |
Why?
|
Databases, Factual | 2 | 2018 | 8080 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4860 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 2029 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1162 | 0.100 |
Why?
|
Consensus | 2 | 2021 | 3212 | 0.100 |
Why?
|
Prevalence | 4 | 2018 | 15869 | 0.100 |
Why?
|
Ischemia | 1 | 2021 | 1900 | 0.100 |
Why?
|
Brain | 2 | 2018 | 27360 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2894 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4120 | 0.100 |
Why?
|
Body Height | 2 | 2008 | 1565 | 0.100 |
Why?
|
Blood Pressure | 6 | 2020 | 8543 | 0.090 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2784 | 0.090 |
Why?
|
Cross Infection | 1 | 2020 | 1426 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1907 | 0.090 |
Why?
|
Radiation Dosage | 1 | 2019 | 1967 | 0.090 |
Why?
|
Fever | 1 | 2018 | 1614 | 0.090 |
Why?
|
Pyridones | 1 | 2016 | 819 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1662 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2020 | 1791 | 0.090 |
Why?
|
Spironolactone | 1 | 2014 | 415 | 0.090 |
Why?
|
Apoptosis | 4 | 2007 | 9523 | 0.090 |
Why?
|
Decision Support Systems, Clinical | 1 | 2019 | 1178 | 0.090 |
Why?
|
Myoglobin | 2 | 2009 | 158 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4352 | 0.090 |
Why?
|
Myocardial Contraction | 4 | 2008 | 1525 | 0.090 |
Why?
|
Mice | 13 | 2023 | 82029 | 0.090 |
Why?
|
Adaptation, Physiological | 2 | 2007 | 1312 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2021 | 20227 | 0.080 |
Why?
|
Drug Interactions | 2 | 2022 | 1419 | 0.080 |
Why?
|
Exercise | 1 | 2006 | 5955 | 0.080 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2008 | 353 | 0.080 |
Why?
|
Shock, Septic | 3 | 2021 | 774 | 0.080 |
Why?
|
Nitric Oxide | 3 | 2007 | 2146 | 0.080 |
Why?
|
Comorbidity | 3 | 2021 | 10590 | 0.080 |
Why?
|
Cardiovascular System | 1 | 2016 | 841 | 0.080 |
Why?
|
Pandemics | 4 | 2022 | 8748 | 0.080 |
Why?
|
Adolescent | 11 | 2023 | 89169 | 0.080 |
Why?
|
Troponin I | 2 | 2024 | 662 | 0.080 |
Why?
|
Heart Valve Diseases | 2 | 2006 | 1030 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2167 | 0.080 |
Why?
|
Positron-Emission Tomography | 2 | 2023 | 6669 | 0.080 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11244 | 0.080 |
Why?
|
Disease Models, Animal | 4 | 2016 | 18349 | 0.080 |
Why?
|
Aldosterone | 1 | 2013 | 881 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10760 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2021 | 5349 | 0.070 |
Why?
|
Pyrazoles | 1 | 2018 | 2028 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2019 | 3474 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2016 | 1309 | 0.070 |
Why?
|
Skating | 1 | 2007 | 20 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1883 | 0.070 |
Why?
|
Cor Triatriatum | 1 | 2007 | 14 | 0.070 |
Why?
|
Body Surface Area | 1 | 2008 | 205 | 0.070 |
Why?
|
Capillaries | 1 | 2010 | 755 | 0.070 |
Why?
|
Body Weight | 2 | 2008 | 4627 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3533 | 0.070 |
Why?
|
Dobutamine | 1 | 2007 | 116 | 0.070 |
Why?
|
Weight Loss | 1 | 2018 | 2721 | 0.070 |
Why?
|
Cardiotonic Agents | 2 | 2007 | 542 | 0.070 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 2006 | 48 | 0.070 |
Why?
|
Myxoma | 1 | 2007 | 114 | 0.070 |
Why?
|
Heart Transplantation | 2 | 2021 | 3301 | 0.070 |
Why?
|
Aortic Valve | 2 | 2007 | 1970 | 0.070 |
Why?
|
Random Allocation | 2 | 2013 | 2396 | 0.070 |
Why?
|
Ships | 1 | 2006 | 53 | 0.070 |
Why?
|
Viridans Streptococci | 1 | 2006 | 16 | 0.070 |
Why?
|
Echocardiography, Stress | 1 | 2007 | 138 | 0.070 |
Why?
|
Vaccination | 1 | 2019 | 3437 | 0.070 |
Why?
|
Myocardial Ischemia | 2 | 2014 | 2138 | 0.070 |
Why?
|
Myocardial Stunning | 1 | 2006 | 67 | 0.070 |
Why?
|
Pilot Projects | 3 | 2016 | 8741 | 0.070 |
Why?
|
Creatine Kinase, MB Form | 1 | 2006 | 202 | 0.070 |
Why?
|
Body Constitution | 1 | 2006 | 273 | 0.070 |
Why?
|
Sclerosing Solutions | 1 | 2006 | 79 | 0.070 |
Why?
|
Europe | 2 | 2024 | 3436 | 0.070 |
Why?
|
Superoxides | 1 | 2007 | 389 | 0.070 |
Why?
|
Pyrimidines | 1 | 2018 | 3048 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11878 | 0.060 |
Why?
|
Vascular Fistula | 1 | 2006 | 50 | 0.060 |
Why?
|
Balloon Occlusion | 1 | 2007 | 129 | 0.060 |
Why?
|
Heart Murmurs | 1 | 2006 | 92 | 0.060 |
Why?
|
Aortic Valve Insufficiency | 2 | 2007 | 577 | 0.060 |
Why?
|
Luminescent Measurements | 1 | 2007 | 342 | 0.060 |
Why?
|
Probability | 2 | 2008 | 2479 | 0.060 |
Why?
|
Algorithms | 3 | 2021 | 14164 | 0.060 |
Why?
|
Intracranial Embolism | 1 | 2007 | 188 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 26379 | 0.060 |
Why?
|
Solvents | 1 | 2006 | 298 | 0.060 |
Why?
|
Paraganglioma | 1 | 2006 | 143 | 0.060 |
Why?
|
Ventricular Myosins | 1 | 2024 | 65 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2024 | 2568 | 0.060 |
Why?
|
bcl-X Protein | 1 | 2006 | 412 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1014 | 0.060 |
Why?
|
Survivors | 1 | 2015 | 2381 | 0.060 |
Why?
|
Diastole | 1 | 2006 | 785 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2017 | 3007 | 0.060 |
Why?
|
Phenotype | 3 | 2017 | 16726 | 0.060 |
Why?
|
Embolism | 1 | 2007 | 401 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6974 | 0.060 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2006 | 141 | 0.060 |
Why?
|
Radionuclide Imaging | 2 | 2024 | 2000 | 0.060 |
Why?
|
Atrial Appendage | 1 | 2007 | 285 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2010 | 1429 | 0.060 |
Why?
|
Systole | 1 | 2006 | 937 | 0.060 |
Why?
|
3-Iodobenzylguanidine | 1 | 2024 | 115 | 0.050 |
Why?
|
Prolapse | 1 | 2023 | 63 | 0.050 |
Why?
|
Peroxidase | 1 | 2006 | 610 | 0.050 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2023 | 89 | 0.050 |
Why?
|
Hemodynamics | 3 | 2013 | 4194 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2008 | 14488 | 0.050 |
Why?
|
Biopsy | 3 | 2021 | 6793 | 0.050 |
Why?
|
Arteriovenous Malformations | 1 | 2006 | 396 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2019 | 4573 | 0.050 |
Why?
|
Reactive Oxygen Species | 2 | 2007 | 2149 | 0.050 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2023 | 211 | 0.050 |
Why?
|
Neoplasm Transplantation | 1 | 2006 | 2014 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2006 | 1375 | 0.050 |
Why?
|
Streptococcal Infections | 1 | 2006 | 619 | 0.050 |
Why?
|
Benzazepines | 1 | 2023 | 308 | 0.050 |
Why?
|
Receptor, erbB-2 | 2 | 2024 | 2603 | 0.050 |
Why?
|
Ultrasonography | 3 | 2016 | 6004 | 0.050 |
Why?
|
Lipopolysaccharides | 1 | 2009 | 2219 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1169 | 0.050 |
Why?
|
Odds Ratio | 1 | 2013 | 9669 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2006 | 649 | 0.050 |
Why?
|
Societies, Medical | 2 | 2024 | 3968 | 0.040 |
Why?
|
Superinfection | 1 | 2021 | 62 | 0.040 |
Why?
|
Osteopontin | 1 | 2022 | 306 | 0.040 |
Why?
|
Ritonavir | 1 | 2022 | 331 | 0.040 |
Why?
|
Diplopia | 1 | 2022 | 217 | 0.040 |
Why?
|
Thrombosis | 2 | 2021 | 2957 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2007 | 9561 | 0.040 |
Why?
|
Proteinuria | 1 | 2023 | 611 | 0.040 |
Why?
|
Autoantigens | 1 | 2024 | 890 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 140 | 0.040 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2007 | 952 | 0.040 |
Why?
|
Severity of Illness Index | 5 | 2012 | 15948 | 0.040 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2007 | 707 | 0.040 |
Why?
|
Massachusetts | 3 | 2021 | 8890 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 125 | 0.040 |
Why?
|
Endocardium | 1 | 2021 | 249 | 0.040 |
Why?
|
Ethanol | 1 | 2006 | 1331 | 0.040 |
Why?
|
Polysomnography | 2 | 2020 | 1871 | 0.040 |
Why?
|
Chronic Disease | 3 | 2014 | 9384 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2022 | 652 | 0.040 |
Why?
|
Microscopy | 1 | 2024 | 909 | 0.040 |
Why?
|
Quebec | 1 | 2019 | 139 | 0.040 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2023 | 775 | 0.040 |
Why?
|
Adrenal Gland Diseases | 1 | 2020 | 141 | 0.040 |
Why?
|
Exercise Tolerance | 1 | 2024 | 846 | 0.040 |
Why?
|
HSP72 Heat-Shock Proteins | 2 | 2009 | 40 | 0.040 |
Why?
|
Urogenital Neoplasms | 1 | 2020 | 130 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4580 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 3740 | 0.040 |
Why?
|
Cell Division | 1 | 2006 | 4473 | 0.040 |
Why?
|
American Heart Association | 1 | 2023 | 1050 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 938 | 0.040 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2006 | 1566 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2006 | 6124 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7951 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2008 | 1323 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1737 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 18065 | 0.040 |
Why?
|
Meglumine | 1 | 2018 | 144 | 0.040 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2024 | 1149 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 488 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 788 | 0.040 |
Why?
|
Swine | 1 | 2008 | 5995 | 0.040 |
Why?
|
Echocardiography, Doppler, Pulsed | 2 | 2007 | 69 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1801 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 549 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2023 | 3858 | 0.030 |
Why?
|
Myositis | 1 | 2020 | 269 | 0.030 |
Why?
|
Protons | 1 | 2022 | 1113 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2020 | 3620 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2006 | 1946 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2008 | 1605 | 0.030 |
Why?
|
Thoracic Neoplasms | 1 | 2019 | 269 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2021 | 610 | 0.030 |
Why?
|
Dyspnea | 2 | 2019 | 1352 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2007 | 3139 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2021 | 772 | 0.030 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2020 | 329 | 0.030 |
Why?
|
Sarcoma | 1 | 2007 | 1806 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2024 | 2253 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2575 | 0.030 |
Why?
|
Extremities | 1 | 2021 | 870 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2024 | 1203 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2019 | 496 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2020 | 667 | 0.030 |
Why?
|
Injections, Intravenous | 2 | 2008 | 1377 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2018 | 648 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2017 | 825 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2661 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1397 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4176 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2024 | 2747 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3228 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1646 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2540 | 0.030 |
Why?
|
Adenine | 1 | 2018 | 995 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 2916 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2227 | 0.030 |
Why?
|
Body Water | 1 | 2013 | 340 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2013 | 6229 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3135 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 2018 | 945 | 0.020 |
Why?
|
Androgen Antagonists | 1 | 2020 | 1412 | 0.020 |
Why?
|
Hypertrophy | 1 | 2013 | 562 | 0.020 |
Why?
|
Cell Size | 1 | 2013 | 626 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4793 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2006 | 3683 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2006 | 12800 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1793 | 0.020 |
Why?
|
Proteomics | 1 | 2024 | 3912 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 9015 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3109 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 2021 | 1292 | 0.020 |
Why?
|
Patient Care Team | 1 | 2021 | 2523 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1667 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4648 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2235 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2726 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2566 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11928 | 0.020 |
Why?
|
Quercetin | 1 | 2009 | 97 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2021 | 3073 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2830 | 0.020 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 2008 | 80 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2163 | 0.020 |
Why?
|
Malondialdehyde | 1 | 2008 | 113 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2462 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2016 | 14783 | 0.020 |
Why?
|
Triiodobenzoic Acids | 1 | 2007 | 123 | 0.020 |
Why?
|
Organ Size | 1 | 2012 | 2267 | 0.020 |
Why?
|
Mesenteric Artery, Superior | 1 | 2007 | 96 | 0.020 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2007 | 93 | 0.020 |
Why?
|
Heart Valve Prosthesis | 2 | 2006 | 1468 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2008 | 624 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2862 | 0.020 |
Why?
|
Physical Education and Training | 1 | 2007 | 102 | 0.020 |
Why?
|
Creatine Kinase | 1 | 2009 | 684 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7243 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2024 | 4887 | 0.020 |
Why?
|
Xanthine Oxidase | 1 | 2006 | 69 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2257 | 0.020 |
Why?
|
Embolectomy | 1 | 2007 | 130 | 0.020 |
Why?
|
Sepsis | 1 | 2021 | 2608 | 0.020 |
Why?
|
Sarcoplasmic Reticulum | 1 | 2006 | 164 | 0.020 |
Why?
|
Paresis | 1 | 2007 | 177 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 7064 | 0.020 |
Why?
|
Aortography | 1 | 2007 | 422 | 0.020 |
Why?
|
Infant | 1 | 2008 | 36535 | 0.020 |
Why?
|
Graft Survival | 1 | 2016 | 3887 | 0.020 |
Why?
|
Endotoxemia | 1 | 2006 | 198 | 0.020 |
Why?
|
Allopurinol | 1 | 2006 | 202 | 0.020 |
Why?
|
Heart Septum | 1 | 2006 | 304 | 0.020 |
Why?
|
Child, Preschool | 1 | 2008 | 42669 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9419 | 0.010 |
Why?
|
Collagen | 1 | 2013 | 2643 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1892 | 0.010 |
Why?
|
Syncope | 1 | 2007 | 430 | 0.010 |
Why?
|
Bundle-Branch Block | 1 | 2006 | 278 | 0.010 |
Why?
|
Endotoxins | 1 | 2006 | 519 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10399 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5703 | 0.010 |
Why?
|
Pulmonary Edema | 1 | 2006 | 408 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2007 | 1587 | 0.010 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2006 | 238 | 0.010 |
Why?
|
Nausea | 1 | 2006 | 682 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2006 | 342 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2006 | 633 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4492 | 0.010 |
Why?
|
Endosonography | 1 | 2007 | 626 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2007 | 877 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5315 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2006 | 1169 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5889 | 0.010 |
Why?
|
HIV-1 | 1 | 2019 | 6961 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14729 | 0.010 |
Why?
|
Incidental Findings | 1 | 2007 | 698 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2007 | 1622 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2006 | 1083 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4772 | 0.010 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2006 | 362 | 0.010 |
Why?
|
Creatinine | 1 | 2007 | 1918 | 0.010 |
Why?
|
Antioxidants | 1 | 2009 | 1673 | 0.010 |
Why?
|
Oxygen | 1 | 2012 | 4270 | 0.010 |
Why?
|
Aortic Valve Stenosis | 1 | 2013 | 2032 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5863 | 0.010 |
Why?
|
Hypotension | 1 | 2006 | 888 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2007 | 1426 | 0.010 |
Why?
|
Pacemaker, Artificial | 1 | 2006 | 828 | 0.010 |
Why?
|
Prosthesis-Related Infections | 1 | 2006 | 497 | 0.010 |
Why?
|
Canada | 1 | 2006 | 2130 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2006 | 948 | 0.010 |
Why?
|
Thromboembolism | 1 | 2006 | 1004 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10873 | 0.010 |
Why?
|
Child | 1 | 2008 | 80917 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13290 | 0.010 |
Why?
|
Preoperative Care | 1 | 2006 | 2258 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2006 | 1398 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 1481 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 6983 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3728 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8317 | 0.010 |
Why?
|
Image Enhancement | 1 | 2006 | 2880 | 0.010 |
Why?
|
Calcium | 1 | 2006 | 5792 | 0.010 |
Why?
|
Survival Analysis | 1 | 2006 | 10101 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2007 | 19015 | 0.010 |
Why?
|
Research Design | 1 | 2006 | 6211 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2007 | 9118 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2006 | 15832 | 0.000 |
Why?
|